As of 2026-04-01, 司美格鲁肽系列产品's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 2.63%, above the industry average by 0.9 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (2.63%) has exceeded positive (2.63%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 司美格鲁肽系列产品's overall mention rate surpasses 2 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
司美格鲁肽系列产品's Mention Rate is 2.63%, lower than 0.6% of competitors
司美格鲁肽系列产品's First Mention is 0.00%, lower than 0.9% of competitors
司美格鲁肽系列产品's Preferred Rate is 0.00%, lower than 100.0% of competitors
司美格鲁肽系列产品's Positive Rate is 2.63%, lower than 8.9% of competitors
司美格鲁肽系列产品's Negative Rate is 2.63%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| RRinvoq | 7.89% | 0% | 0% | 5.26% | 0% | View Details |
| ZZepbound | 5.26% | 0% | 0% | 5.26% | 0% | View Details |
| 度度普利尤单抗 | 5.26% | 0% | 0% | 2.63% | 0% | View Details |
| MMounjaro | 2.63% | 0% | 0% | 2.63% | 0% | View Details |
| 司司美格鲁肽系列产品 (Current Brand) | 2.63% | 0% | 0% | 2.63% | 2.63% | View Details |
| KKeytruda | 0% | 0% | 0% | 0% | 0% | View Details |
| OOcrevus | 0% | 0% | 0% | 0% | 0% | View Details |
